New appointment at Sandoz
This article was originally published in Scrip
Executive Summary
Sandoz (Novartis) has appointed Christine Mundkur chief executive officer of its US generic operations and head of commercial operations for North America. She was most recently chief executive officer of Barr Laboratories, having previously served as executive vice-president of global quality, safety and regulatory affairs.